SLC25A20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.888000E-01
Normal-vs-Stage2
8.193000E-01
Normal-vs-Stage3
2.394400E-01
Normal-vs-Stage4
8.693600E-01
Stage1-vs-Stage2
1.731580E-01
Stage1-vs-Stage3
7.108100E-02
Stage1-vs-Stage4
3.863200E-01
Stage2-vs-Stage3
1.841580E-01
Stage2-vs-Stage4
9.481400E-01
Stage3-vs-Stage4
8.309500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.429400E-01
Normal-vs-AfricanAmerican
5.739600E-01
Normal-vs-Asian
4.310000E-01
Caucasian-vs-AfricanAmerican
1.044400E-01
Caucasian-vs-Asian
4.261400E-01
AfricanAmerican-vs-Asian
1.992400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.702200E-01
Normal-vs-Female
8.315000E-01
Male-vs-Female
9.057200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.716600E-01
Normal-vs-Age(41-60Yrs)
9.740200E-01
Normal-vs-Age(61-80Yrs)
7.601200E-01
Normal-vs-Age(81-100Yrs)
8.948600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.403200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.920000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.238600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.267600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.641600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.729200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.232000E-01
Normal-vs-Daily Drinker
5.927000E-01
Normal-vs-Weekly Drinker
7.657600E-01
Normal-vs-Occasional Drinker
6.334400E-01
Normal-vs-Social Drinker
7.026200E-01
Non Drinker-vs-Daily Drinker
8.355000E-01
Non Drinker-vs-Weekly Drinker
9.507600E-01
Non Drinker-vs-Occasional Drinker
9.993600E-01
Non Drinker-vs-Social Drinker
9.331400E-01
Daily Drinker-vs-Weekly Drinker
8.444000E-01
Daily Drinker-vs-Occasional Drinker
8.538800E-01
Daily Drinker-vs-Social Drinker
8.090400E-01
Weekly Drinker-vs-Occasional Drinker
9.564000E-01
Weekly Drinker-vs-Social Drinker
9.936000E-01
Occasional Drinker-vs-Social Drinker
9.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.273840E-01
Normal-vs-Grade 2
9.429700E-02
Normal-vs-Grade 3
7.444300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.137200E-01
Grade 1-vs-Grade 3
7.045600E-01
Grade 1-vs-Grade 4
1.273840E-01
Grade 2-vs-Grade 3
5.377000E-01
Grade 2-vs-Grade 4
9.429700E-02
Grade 3-vs-Grade 4
7.444300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.857200E-01
Normal-vs-NonDiabetic
7.534400E-01
Diabetic-vs-NonDiabetic
8.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.205200E-01
Normal-vs-NoPancreatitis
6.851400E-01
Pancreatitis-vs-NoPancreatitis
1.668230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.533400E-01
Normal-vs-N1
7.852000E-01
N0-vs-N1
3.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.057800E-01
Normal-vs-TP53-NonMutant
9.762600E-01
TP53-Mutant-vs-TP53-NonMutant
3.933500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
